Alzheimer’s disease patients showed decreased expression of SIRT6 and mice lacking SIRT6 showed TAU protein stabilization and increased phosphorylation, via the activation of the glycogen synthase kinase 3 (GSK3) (Kaluski et al., 2017). This evidence concerns the gene SIRT6 and early-onset autosomal dominant Alzheimer disease.